help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, T.
Right arrow Articles by Bardin, C. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, T.
Right arrow Articles by Bardin, C. W.

Endocrinology, Vol 125, 2134-2140, Copyright © 1989 by Endocrine Society


ARTICLES

Regulation of Leydig cell function in primary culture by inhibin and activin

T Lin, JK Calkins, PL Morris, W Vale and CW Bardin
Medical Service, WJB Dorn Veterans' Hospital, Columbia, South Carolina 29201.

Inhibin and activin are gonadal glycoproteins that selectively inhibit and stimulate FSH release, respectively. Previously we have reported that transforming growth factor-beta inhibited hCG-stimulated testosterone formation in mature Leydig cells. In the present study we evaluated the effects of other members of the transforming growth factor-beta family, inhibin and activin, on Leydig cell function. We found that activin (0.1-10 ng/ml) had no effect on basal testosterone formation, but inhibited hCG-stimulated testosterone formation in a dose-dependent manner. Activin (10 ng/ml) inhibited hCG-stimulated testosterone formation by 42%. Activin also inhibited hCG-stimulated cAMP formation. In the presence of activin (5 ng/ml), forskolin (10 microM)- and 8-bromo-cAMP (0.1 mM)-induced testosterone formation were reduced about one third. Conversions of pregnenolone and progesterone to testosterone were also blocked by activin. Interestingly, [125I]hCG binding to Leydig cells and forskolin-induced cAMP formation were not affected by the addition of activin. In contrast to activin, inhibin (0.1-10 ng/ml) had no effect on hCG-induced testosterone formation at any concentration used. However, the inhibitory effects of activin on Leydig cell function were reversed by the concomitant addition of inhibin. Our results suggest that activin inhibits testosterone formation by the Leydig cells derived from normal mature rats. Multiple steps of the steroidogenic pathway are affected by testosterone. Inhibin alone has no effect, but reverses the inhibitory action of activin.


This article has been cited by other articles:


Home page
Biol. Reprod.Home page
Y.-F. Chan, F. Tang, and W.-S. O
Adrenomedullin in the Rat Testis. II: Its Production, Actions on Inhibin Secretion, Regulation by Follicle-Stimulating Hormone, and Its Interaction with Endothelin 1 in the Sertoli Cell
Biol Reprod, April 1, 2008; 78(4): 780 - 785.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
K. Warita, K. Okamoto, K.-i. Mutoh, Y. Hasegawa, Z.-P. Yue, T. Yokoyama, Y. Matsumoto, T. Miki, Y. Takeuchi, H. Kitagawa, et al.
Activin A and Equine Chorionic Gonadotropin Recover Reproductive Dysfunction Induced by Neonatal Exposure to an Estrogenic Endocrine Disruptor in Adult Male Mice
Biol Reprod, January 1, 2008; 78(1): 59 - 67.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
Y.-C. Chen, R. K Cochrum, M. T Tseng, D. T Ghooray, J. P Moore, S. J Winters, and B. J Clark
Effects of CDB-4022 on Leydig Cell Function in Adult Male Rats
Biol Reprod, December 1, 2007; 77(6): 1017 - 1026.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
N. Renlund, F. H O'Neill, L. Zhang, Y. Sidis, and J. Teixeira
Activin receptor-like kinase-2 inhibits activin signaling by blocking the binding of activin to its type II receptor
J. Endocrinol., October 1, 2007; 195(1): 95 - 103.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. G. Farnworth, P. G. Stanton, Y. Wang, R. Escalona, J. K. Findlay, and G. T. Ooi
Inhibins Differentially Antagonize Activin and Bone Morphogenetic Protein Action in a Mouse Adrenocortical Cell Line
Endocrinology, July 1, 2006; 147(7): 3462 - 3471.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
S. A. Sweeney and P. A. Johnson
Messenger RNA and Protein Expression Analysis of Betaglycan in the Pituitary and Ovary of the Domestic Hen
Biol Reprod, January 1, 2005; 72(1): 172 - 178.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
H. Kaneko, J. Noguchi, K. Kikuchi, and Y. Hasegawa
Molecular Weight Forms of Inhibin A and Inhibin B in the Bovine Testis Change with Age
Biol Reprod, May 1, 2003; 68(5): 1918 - 1925.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
D. J. Bernard
Editorial Commentary: SMAD Expression in the Testis Predicts Age- and Cell-Specific Responses to Activin and TGF{beta}
J Androl, March 1, 2003; 24(2): 201 - 203.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. A. Pangas, A. W. Rademaker, D. A. Fishman, and T. K. Woodruff
Localization of the Activin Signal Transduction Components in Normal Human Ovarian Follicles: Implications for Autocrine and Paracrine Signaling in the Ovary
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2644 - 2657.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. C. Chapman and T. K. Woodruff
Modulation of Activin Signal Transduction by Inhibin B and Inhibin-Binding Protein (InhBP)
Mol. Endocrinol., April 1, 2001; 15(4): 668 - 679.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
C. A. Harrison, P. G. Farnworth, K. L. Chan, P. G. Stanton, G. T. Ooi, J. K. Findlay, and D. M. Robertson
Identification of Specific Inhibin A-Binding Proteins on Mouse Leydig (TM3) and Sertoli (TM4) Cell Lines
Endocrinology, April 1, 2001; 142(4): 1393 - 1402.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
H. Mizunuma, X. Liu, K. Andoh, Y. Abe, J. Kobayashi, K. Yamada, H. Yokota, Y. Ibuki, and Y. Hasegawa
Activin from Secondary Follicles Causes Small Preantral Follicles to Remain Dormant at the Resting Stage
Endocrinology, January 1, 1999; 140(1): 37 - 42.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
H. Lejeune, F. Chuzel, P. Sanchez, P. Durand, J. P. Mather, and J. M. Saez
Stimulating Effect of Both Human Recombinant Inhibin A and Activin A on Immature Porcine Leydig Cell Functions in Vitro
Endocrinology, November 1, 1997; 138(11): 4783 - 4791.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
L. Gnessi, A. Fabbri, and G. Spera
Gonadal Peptides as Mediators of Development and Functional Control of the Testis: An Integrated System with Hormones and Local Environment
Endocr. Rev., August 1, 1997; 18(4): 541 - 609.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. Majdic, A. S. McNeilly, R. M. Sharpe, L. R. Evans, N. P. Groome, and P. T. K. Saunders
Testicular Expression of Inhibin and Activin Subunits and Follistatin in the Rat and Human Fetus and Neonate and During Postnatal Development in the Rat
Endocrinology, May 1, 1997; 138(5): 2136 - 2147.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society